Amogh Kothare is the new Chief Scientific Officer of Advalight.
In this role, Mr. Kothare will be responsible for clinical research, partnerships, product management, and clinical affairs and training to further leverage the brand. A
“Under Amogh’s scientific and clinical leadership, we intend to strengthen and expand our clinical research partnerships with leading physicians in the U.S. and globally,” says Jacob L. Philipsen, CEO of Advalight, in a news release. “We firmly believe that Amogh’s industry insight and deep understanding of user and patient needs, combined with our world-class engineering team, will take our product offerings and thereby our company to the next level and beyond.”
Prior to joining Advalight, Mr. Kothare served in a similar role at Cutera.
“I have been a part of the aesthetic industry for almost two decades and was really impressed with Advalight’s pioneering technology, and their desire to put science and technology at the forefront of their product development efforts,” Mr. Kothare says. “I am grateful to be a part of this team, and I look forward to collectively making Advalight the next big thing in aesthetics and medical dermatology.”
“Adding Amogh to lead our talented team of engineers is an exciting leap forward in the evolution of Advalight, both from a future product development standpoint, and for the continuing optimization of the current ADVATx platform,” says President of Advalight Corp Travis Mahan. “I’m personally beyond excited and grateful to welcome Amogh to the Advalight family.”
Advalight makes the dual 589nm and 1319nm wavelength ADVATx solid-state laser.
